GNAI2

G Protein Subunit Alpha i2

Gene Information Card

Symbol GNAI2
Full Name G Protein Subunit Alpha i2
Gene Type protein-coding
Chromosomal Location 3p21.31
NCBI Gene ID 2771 ncbi.nlm.nih.gov/gene/2771
Ensembl ID ENSG00000114353
UniProt ID P04899
OMIM ID 139320
HGNC ID 4385
Aliases GNAI2, GIP, GNAI2B, H_LUCA15.1, G protein alpha i2

Description

GNAI2 encodes the alpha subunit of the heterotrimeric G protein Gi2, which inhibits adenylyl cyclase and modulates intracellular cAMP levels. It plays a critical role in signal transduction from G protein-coupled receptors (GPCRs) and is involved in cell proliferation, migration, and differentiation. Mutations and altered expression of GNAI2 are implicated in various cancers and endocrine disorders.

Disease Associations

Disease category Pathophysiological mechanism Genomic evidence
Pituitary adenoma (McCune-Albright syndrome-like) Activating mutations in GNAI2 lead to constitutive cAMP signaling, promoting hormone secretion and cell proliferation. OMIM #139320; PMID: 2549426
Ovarian cancer GNAI2 overexpression or gain-of-function mutations enhance oncogenic signaling via MAPK and PI3K pathways. COSMIC; PMID: 21552269
Breast cancer Altered GNAI2 expression correlates with poor prognosis and metastasis through modulation of cAMP and Rho pathways. PMID: 23542345
Colorectal cancer GNAI2 mutations (e.g., R179C) are recurrent and associated with Wnt/β-catenin pathway activation. COSMIC; PMID: 23542345

Expression Profile

Tissue Expression
Tissue nTPM level
Brain 12.5 Medium
Heart 8.3 Medium
Lung 10.1 Medium
Liver 6.7 Low
Kidney 9.4 Medium
Ovary 11.2 Medium
Breast 7.8 Medium
Colon 9.9 Medium
Cell Line Expression
Cell Line nTPM Notes
HEK293 15.2 High expression
HeLa 12.8 High expression
MCF7 10.5 Medium expression
A549 9.1 Medium expression
HCT116 11.7 High expression
Data source:Human Protein Atlas(proteinatlas.org)

Mutations & Variants

Hotspot Mutations
Variant Type Frequency Functional Description
R179C Missense <1% (cancer) Gain-of-function; reduces GTPase activity, leading to constitutive activation.
R179H Missense <1% (cancer) Gain-of-function; similar to R179C, found in pituitary adenomas.
Q205L Missense <1% (cancer) Gain-of-function; impairs GTP hydrolysis, persistent signaling.
G203R Missense <1% (cancer) Gain-of-function; associated with uveal melanoma.
Mutation functional classification

Loss of Function (LOF)

Rare; reported in some developmental disorders but not well characterized.

Gain of Function (GOF)

Common in cancer; mutations at codons 179, 205, and 203 impair GTPase activity, leading to constitutive GPCR signaling.

Dominant Negative (DN)

Not well documented for GNAI2.

Gene Ontology (GO)

G protein-coupled receptor signaling pathway (GO:0007186) • adenylate cyclase-inhibiting G protein-coupled receptor signaling pathway (GO:0007193)
GTPase activity (GO:0003924) GTP binding (GO:0005525)
signal transduction (GO:0007165) cell proliferation (GO:0008283)

Pathways

GPCR downstream signaling (Reactome: R-HSA-388396)
cAMP signaling pathway (KEGG: hsa04024)
MAPK signaling pathway (KEGG: hsa04010)
PI3K-Akt signaling pathway (KEGG: hsa04151)

Protein Summary

GNAI2 encodes the alpha i2 subunit of heterotrimeric G proteins. The protein binds GTP and hydrolyzes it to GDP, acting as a molecular switch that inhibits adenylyl cyclase and reduces cAMP levels. It is ubiquitously expressed and mediates signals from numerous GPCRs. Gain-of-function mutations are oncogenic, particularly in pituitary, ovarian, and colorectal cancers.

Related Products

Product name Cat.No. Species Gene ID
GNAI2 Knockout HEK293 Cell Line EDJ-KQ1318 Human 2771 Details Get a Quote
GNAI2 Knockout A-549 Cell Line EDJ-KQ20747 Human 2771 Details Get a Quote
GNAI2 Knockout HCT 116 Cell Line EDJ-KQ20748 Human 2771 Details Get a Quote
GNAI2 Knockout HeLa Cell Line EDJ-KQ20749 Human 2771 Details Get a Quote
Displaying Records 1 To 4 Of 4 Records
Contact Us
*
*
*
*
How did you hear about us: